TrialClinical pharmacology in drug development2021

A Phase 1 Study of KHK4083: A Single-Blind, Randomized, Placebo-Controlled Single-Ascending-Dose Study in Healthy Adults and an Open-Label Multiple-Dose Study in Patients With Ulcerative Colitis.

Kenichi Furihata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.